Giuseppe Roscilli
Takeda (Italy)(IT)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Virus-based gene therapy research, Lung Cancer Treatments and Mutations, Cancer Cells and Metastasis
Most-Cited Works
- → Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors(2009)308 cited
- → Mismatch repair deficiency associated with overexpression of the MSH3 gene(1998)210 cited
- → SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines(2020)197 cited
- → Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ(2017)165 cited
- → Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells(2013)153 cited
- → Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections(2022)122 cited
- → Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans -Activators(2002)92 cited
- → Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates(2003)85 cited
- → Epigenetic silencing of miR-145-5p contributes to brain metastasis(2015)84 cited
- → The promise of anti-ErbB3 monoclonals as new cancer therapeutics(2012)81 cited